205.24 - 207.41
139.95 - 221.69
4.54M / 6.54M (Avg.)
37.59 | 5.48
Helps investors judge whether earnings growth is driven by sustainable operations or temporary factors. Consistent, organic income expansion can justify a higher intrinsic value for patient, long-term investors.
-51.02%
Revenue decline while MRVL shows 4.29% growth. Joel Greenblatt would examine competitive position erosion.
-52.73%
Cost reduction while MRVL shows 4.77% growth. Joel Greenblatt would examine competitive advantage.
-46.54%
Gross profit decline while MRVL shows 3.82% growth. Joel Greenblatt would examine competitive position.
9.15%
Margin expansion while MRVL shows decline. John Neff would investigate competitive advantages.
-55.80%
R&D reduction while MRVL shows 1.74% growth. Joel Greenblatt would examine competitive risk.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-34.72%
Both companies reducing operating expenses. Martin Whitman would check industry trends.
-46.87%
Total costs reduction while MRVL shows 2.65% growth. Joel Greenblatt would examine advantage.
No Data
No Data available this quarter, please select a different quarter.
120.00%
D&A growth above 1.5x MRVL's 1.23%. Michael Burry would check for excessive investment.
-7.91%
EBITDA decline while MRVL shows 4.17% growth. Joel Greenblatt would examine position.
-120.30%
Both companies show margin pressure. Martin Whitman would check industry conditions.
-55.20%
Operating income decline while MRVL shows 15.99% growth. Joel Greenblatt would examine position.
-216.85%
Operating margin decline while MRVL shows 5.31% growth. Joel Greenblatt would examine position.
-250.00%
Both companies reducing other expenses. Martin Whitman would check industry patterns.
-66.92%
Pre-tax income decline while MRVL shows 8.06% growth. Joel Greenblatt would examine position.
-240.77%
Pre-tax margin decline while MRVL shows 3.62% growth. Joel Greenblatt would examine position.
-666.67%
Tax expense reduction while MRVL shows 9600.00% growth. Joel Greenblatt would examine advantage.
80.95%
Net income growth while MRVL declines. John Neff would investigate advantages.
61.11%
Net margin growth while MRVL declines. John Neff would investigate advantages.
81.13%
EPS growth while MRVL declines. John Neff would investigate advantages.
81.13%
Diluted EPS growth while MRVL declines. John Neff would investigate advantages.
0.19%
Share count increase while MRVL reduces shares. John Neff would investigate differences.
0.19%
Diluted share reduction exceeding 1.5x MRVL's 1.17%. David Dodd would verify capital allocation.